Deltex Historical Cash Flow

DEMG Stock

0.08 0.01 6.67%

Analysis of Deltex Medical cash flow over time is an excellent tool to project Deltex Medical Group future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 856.3 K or Depreciation of 152.9 K as it is a great indicator of Deltex Medical ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Deltex Medical Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Deltex Medical Group is a good buy for the upcoming year.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Deltex Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Deltex Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Deltex balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Deltex's non-liquid assets can be easily converted into cash.

Deltex Medical Cash Flow Chart

At this time, Deltex Medical's Change To Liabilities is comparatively stable compared to the past year.

Change In Working Capital Depreciation Capital Expenditures Total Cash From Operating Activities Total Cash From Financing Activities Net Borrowings

Change In Working Capital

The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.

Depreciation

Depreciation indicates how much of Deltex Medical Group value has been used up. For tax purposes Deltex Medical can deduct the cost of the tangible assets it purchases as business expenses. However, Deltex Medical Group must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Capital Expenditures

Capital Expenditures are funds used by Deltex Medical Group to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Deltex Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

Most accounts from Deltex Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Deltex Medical Group current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Deltex Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Deltex Medical's Change To Liabilities is comparatively stable compared to the past year.

Deltex Medical cash flow statement Correlations

	Change To Inventory	Change In Cash	Free Cash Flow	Change In Working Capital	Begin Period Cash Flow	Depreciation	Other Non Cash Items	Capital Expenditures	Net Income	End Period Cash Flow	Change To Account Receivables	Stock Based Compensation	Sale Purchase Of Stock	Net Borrowings	Change To Operating Activities	Change To Netincome	Change To Liabilities	Investments	Issuance Of Capital Stock
Change To Inventory		-0.58	-0.21	0.4	0.31	-0.19	0.02	-0.26	-0.35	-0.37	-0.08	0.05	-0.41	0.02	0.2	0.22	-0.08	-0.15	0.03
Change In Cash	-0.58		-0.16	-0.48	-0.64	-0.17	-0.42	0.13	0.18	0.49	-0.03	-0.16	0.59	0.19	-0.36	-0.18	-0.07	0.07	0.07
Free Cash Flow	-0.21	-0.16		0.37	0.06	0.02	0.14	-0.09	0.76	-0.12	0.56	-0.39	-0.62	-0.48	0.52	-0.44	-0.07	0.62	-0.76
Change In Working Capital	0.4	-0.48	0.37		0.31	0.21	0.18	-0.27	-0.14	-0.19	0.38	-0.13	-0.29	-0.47	0.33	-0.25	-0.08	0.01	-0.31
Begin Period Cash Flow	0.31	-0.64	0.06	0.31		0.44	0.48	-0.04	-0.37	0.35	0.15	0.13	-0.19	-0.41	0.18	-0.04	0.42	-0.11	0.0
Depreciation	-0.19	-0.17	0.02	0.21	0.44		0.03	-0.19	-0.31	0.32	0.07	0.28	0.35	-0.43	-0.04	-0.1	-0.11	0.14	0.43
Other Non Cash Items	0.02	-0.42	0.14	0.18	0.48	0.03		-0.09	-0.23	0.02	0.29	-0.17	-0.38	-0.4	0.35	-0.11	0.75	0.04	-0.04
Capital Expenditures	-0.26	0.13	-0.09	-0.27	-0.04	-0.19	-0.09		0.25	0.12	-0.52	0.34	0.03	0.58	-0.24	0.26	0.32	-0.57	-0.21
Net Income	-0.35	0.18	0.76	-0.14	-0.37	-0.31	-0.23	0.25		-0.21	0.22	-0.37	-0.5	-0.03	0.37	-0.33	-0.21	0.45	-0.73
End Period Cash Flow	-0.37	0.49	-0.12	-0.19	0.35	0.32	0.02	0.12	-0.21		0.12	-0.01	0.54	-0.25	-0.27	-0.24	0.36	-0.05	0.1
Change To Account Receivables	-0.08	-0.03	0.56	0.38	0.15	0.07	0.29	-0.52	0.22	0.12		-0.76	-0.32	-0.65	0.5	-0.69	0.0	0.61	-0.43
Stock Based Compensation	0.05	-0.16	-0.39	-0.13	0.13	0.28	-0.17	0.34	-0.37	-0.01	-0.76		0.4	0.47	-0.75	0.87	-0.07	-0.37	0.46
Sale Purchase Of Stock	-0.41	0.59	-0.62	-0.29	-0.19	0.35	-0.38	0.03	-0.5	0.54	-0.32	0.4		0.21	-0.74	0.2	-0.15	-0.27	0.63
Net Borrowings	0.02	0.19	-0.48	-0.47	-0.41	-0.43	-0.4	0.58	-0.03	-0.25	-0.65	0.47	0.21		-0.55	0.64	-0.05	-0.54	0.12
Change To Operating Activities	0.2	-0.36	0.52	0.33	0.18	-0.04	0.35	-0.24	0.37	-0.27	0.5	-0.75	-0.74	-0.55		-0.72	0.17	0.27	-0.42
Change To Netincome	0.22	-0.18	-0.44	-0.25	-0.04	-0.1	-0.11	0.26	-0.33	-0.24	-0.69	0.87	0.2	0.64	-0.72		-0.06	-0.34	0.4
Change To Liabilities	-0.08	-0.07	-0.07	-0.08	0.42	-0.11	0.75	0.32	-0.21	0.36	0.0	-0.07	-0.15	-0.05	0.17	-0.06		-0.33	-0.09
Investments	-0.15	0.07	0.62	0.01	-0.11	0.14	0.04	-0.57	0.45	-0.05	0.61	-0.37	-0.27	-0.54	0.27	-0.34	-0.33		-0.26
Issuance Of Capital Stock	0.03	0.07	-0.76	-0.31	0.0	0.43	-0.04	-0.21	-0.73	0.1	-0.43	0.46	0.63	0.12	-0.42	0.4	-0.09	-0.26

Click cells to compare fundamentals

Deltex Medical Account Relationship Matchups

Deltex Medical cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Change To Inventory	(235K)	13K	89K	(48K)	105K	110.3K
Change In Cash	328K	(55K)	(440K)	58K	234K	245.7K
Free Cash Flow	349K	(239K)	(935K)	(1.4M)	(1.6M)	(1.6M)
Change In Working Capital	410K	379K	434K	208K	(232K)	(220.4K)
Begin Period Cash Flow	580K	908K	853K	413K	471K	856.3K
Other Cashflows From Financing Activities	(33K)	(40K)	543K	(160K)	(245K)	(232.8K)
Depreciation	233K	143K	114K	128K	133K	152.9K
Other Non Cash Items	189K	104K	(72K)	262K	161K	169.1K
Capital Expenditures	260K	171K	644K	744K	370K	293.0K
Total Cash From Operating Activities	609K	(68K)	(291K)	(606K)	(1.2M)	(1.3M)
Net Income	(161K)	(798K)	(967K)	(1.1M)	(1.3M)	(1.3M)
Total Cash From Financing Activities	(67K)	190K	502K	1.4M	1.8M	1.4M
End Period Cash Flow	908K	853K	413K	471K	705K	780.0K
Change To Account Receivables	427K	680K	148K	(57K)	332K	234.2K
Stock Based Compensation	166K	117K	39K	95K	125K	0.0
Sale Purchase Of Stock	952K	2.2M	322K	253K	227.7K	216.3K
Net Borrowings	(389K)	(60K)	502K	188K	216.2K	227.0K
Total Cashflows From Investing Activities	(201K)	(171K)	(644K)	(744K)	(855.6K)	(898.4K)
Change To Operating Activities	(1K)	6K	(11K)	7K	8.1K	8.5K
Change To Netincome	125K	195K	127K	203K	182.7K	149.0K
Change To Liabilities	212K	(303K)	191K	306K	275.4K	289.2K
Investments	(201K)	(171K)	(644K)	(744K)	(370K)	(388.5K)
Issuance Of Capital Stock	322K	253K	0.0	1.3M	1.9M	1.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Deltex Stock Analysis

When running Deltex Medical's price analysis, check to measure Deltex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Deltex Medical is operating at the current time. Most of Deltex Medical's value examination focuses on studying past and present price action to predict the probability of Deltex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Deltex Medical's price. Additionally, you may evaluate how the addition of Deltex Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC